Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 7;148(19):1509-1510.
doi: 10.1161/CIRCULATIONAHA.123.066622. Epub 2023 Nov 6.

Response by Sipilä and Kivimäki to Letter Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study"

Pyry N Sipilä  1   2 , Mika Kivimäki  1   2   3
Affiliations
Comment

Response by Sipilä and Kivimäki to Letter Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study"

Pyry N Sipilä et al. Circulation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures The analyses presented in this response were conducted using data from the UK Biobank (https://www.ukbiobank.ac.uk/) via application 60565. Dr Sipilä reports grant support from the Finnish Medical Foundation during the writing of the author response. Dr Kivimäki reports grant support from Wellcome Trust (221854/Z/20/Z), UK Medical Research Council (MRC R024227/1), the US National Institute on Aging (R01AG056477), the Academy of Finland (350426), and the Finnish Foundation for Cardiovascular Research (a86898) during the writing of the author response.

Comment on

References

    1. Sipilä PN, Lindbohm JV, Batty GD, Heikkilä N, Vahtera J, Suominen S, Väänänen A, Koskinen A, Nyberg ST, Meri S, et al. Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study. Circulation. 2023;147:1582–1593. - PubMed
    1. Batty GD, Gale CR, Kivimäki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368:m131. - PMC - PubMed
    1. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191–2200. - PMC - PubMed
    1. Writing Committee for the REMAP-CAP Investigators. Lawler PR, Derde LPG, van de Veerdonk FL, McVerry BJ, Huang DT, Berry LR, Lorenzi E, van Kimmenade R, Gommans F, et al. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. JAMA. 2023;329:1183–1196. - PMC - PubMed
    1. Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, Nishida O. Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Chest. 2021;159:2289–2300. - PubMed

MeSH terms